BIOMAT Database Logo BIOMAT Database Logo

The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. 2001

Y M Akkari, and R L Bateman, and C A Reifsteck, and A D D'Andrea, and S B Olson, and M Grompe
Department of Molecular and Medical Genetics, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road L103, Portland, Oregon 97201, USA. akkariy@oshu.edu

Fanconi anemia (FA) is a human genetic disorder characterized by hypersensitivity to DNA crosslinking agents. Its cellular phenotypes include increased chromosome breakage and a marked cell-cycle delay with 4N DNA content after introduction of interstrand DNA crosslinks (ICL). To further understand the nature of this delay previously described as a G2/M arrest, we introduced ICL specifically during G2 and monitored the cells for passage into mitosis. Our results showed that, even at the highest doses, postreplication ICL produced neither G2/M arrest nor chromosome breakage in FA-A or FA-C cells. This suggests that, similar to wild-type cells, DNA replication is required to trigger both responses. Therefore, the 4N cell DNA content observed in FA cells after ICL treatment also represents incomplete DNA replication and arrest in late S phase. FA fibroblasts from complementation groups A and C were able to recover from the ICL-induced cell-cycle arrest, but took approximately 3 times longer than controls. These results indicate that the FA pathway is required for the efficient resolution of ICL-induced S-phase arrest.

UI MeSH Term Description Entries
D008938 Mitosis A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species. M Phase, Mitotic,Mitotic M Phase,M Phases, Mitotic,Mitoses,Mitotic M Phases,Phase, Mitotic M,Phases, Mitotic M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003432 Cross-Linking Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Bifunctional Reagent,Bifunctional Reagents,Cross Linking Reagent,Crosslinking Reagent,Cross Linking Reagents,Crosslinking Reagents,Linking Reagent, Cross,Linking Reagents, Cross,Reagent, Bifunctional,Reagent, Cross Linking,Reagent, Crosslinking,Reagents, Bifunctional,Reagents, Cross Linking,Reagents, Cross-Linking,Reagents, Crosslinking
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D005199 Fanconi Anemia Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id Anemia, Fanconi,Fanconi Hypoplastic Anemia,Fanconi Pancytopenia,Fanconi Panmyelopathy,Fanconi's Anemia,Anemia, Fanconi's,Anemias, Fanconi,Fanconi Anemias
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014307 Trioxsalen Pigmenting photosensitizing agent obtained from several plants, mainly Psoralea corylifolia. It is administered either topically or orally in conjunction with ultraviolet light in the treatment of vitiligo. Trimethylpsoralen,Trioxysalen,2,5,9-Trimethyl-7H-furo(3,2-g)benzopyran-7-one,4,5',8-Trimethylpsoralen,NSC-71047,Trioxisalenum,Trisoralen,NSC 71047,NSC71047
D014466 Ultraviolet Rays That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. Actinic Rays,Black Light, Ultraviolet,UV Light,UV Radiation,Ultra-Violet Rays,Ultraviolet Light,Ultraviolet Radiation,Actinic Ray,Light, UV,Light, Ultraviolet,Radiation, UV,Radiation, Ultraviolet,Ray, Actinic,Ray, Ultra-Violet,Ray, Ultraviolet,Ultra Violet Rays,Ultra-Violet Ray,Ultraviolet Black Light,Ultraviolet Black Lights,Ultraviolet Radiations,Ultraviolet Ray

Related Publications

Y M Akkari, and R L Bateman, and C A Reifsteck, and A D D'Andrea, and S B Olson, and M Grompe
Arrest of S-phase progression is impaired in Fanconi anemia cells.
November 2000, Experimental cell research,
Y M Akkari, and R L Bateman, and C A Reifsteck, and A D D'Andrea, and S B Olson, and M Grompe
Fanconi anemia proteins and the s phase checkpoint.
June 2004, Cell cycle (Georgetown, Tex.),
Y M Akkari, and R L Bateman, and C A Reifsteck, and A D D'Andrea, and S B Olson, and M Grompe
The cell cycle of lymphocytes in Fanconi anemia.
January 1982, Human genetics,
Y M Akkari, and R L Bateman, and C A Reifsteck, and A D D'Andrea, and S B Olson, and M Grompe
Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent edomitosis in Fanconi anemia cells.
September 1985, American journal of human genetics,
Y M Akkari, and R L Bateman, and C A Reifsteck, and A D D'Andrea, and S B Olson, and M Grompe
Indomethacin-induced G1/S phase arrest of the plant cell cycle.
September 1999, FEBS letters,
Y M Akkari, and R L Bateman, and C A Reifsteck, and A D D'Andrea, and S B Olson, and M Grompe
Fanconi anemia. Chromosome breakage and cell cycle studies.
August 1993, Cancer genetics and cytogenetics,
Y M Akkari, and R L Bateman, and C A Reifsteck, and A D D'Andrea, and S B Olson, and M Grompe
Accumulation of p16CDKN2A in response to ultraviolet irradiation correlates with late S-G(2)-phase cell cycle delay.
June 1996, Cancer research,
Y M Akkari, and R L Bateman, and C A Reifsteck, and A D D'Andrea, and S B Olson, and M Grompe
The Fanconi anemia core complex associates with chromatin during S phase.
January 2005, Blood,
Y M Akkari, and R L Bateman, and C A Reifsteck, and A D D'Andrea, and S B Olson, and M Grompe
Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase.
June 1998, Experimental cell research,
Y M Akkari, and R L Bateman, and C A Reifsteck, and A D D'Andrea, and S B Olson, and M Grompe
Fanconi anemia and the cell cycle: new perspectives on aneuploidy.
January 2014, F1000prime reports,
Copied contents to your clipboard!